Occupational Integration of Adults With Severe Haemophilia in France: a Study Based on the FranceCoag Cohort
NCT ID: NCT03301376
Last Updated: 2023-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
590 participants
OBSERVATIONAL
2018-08-28
2020-05-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Life in Adult Patients With Severe Haemophilia in Turkey
NCT01623960
Medication Exposure in Older Patients With Constitutional Hemorrhagic Disease
NCT04282486
Longitudinal Cohort of Thrombosis and Hemostasis Diseases
NCT06727669
Viscosupplementation in Patients With Hemophilic Arthropathy
NCT01748201
Hemostasis Profile in Patients With Severe Subarachnoid Hemorrhage
NCT03745456
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Detailed objectives are mentioned hereinbelow:
1. To assess occupational issues in adults with severe haemophilia in France
2. To assess the impact of the changes of the context of life over the last decades in the new generation of adults with severe haemophilia in France
3. To compare occupational outcomes between adults with severe haemophilia and the general population in France
4. To identify individual characteristics (socio-demographics, clinical and psycho-behavioural) associated with occupational issues in adults with severe haemophilia in France
5. To compare occupational issues between adults with severe haemophilia and adults with others severe chronic childhood diseases in France to identify common and haemophilia-specific issues
Material and methods:
All adults (18-65 y.o.) participating in the FranceCoag cohort, which includes more than 1,500 French adults with severe haemophilia followed-up in 34 Haemophilia Treatment Centres, will be invited to participate in the study. These adults will be identified through the database of the FranceCoag cohort, and will be invited to participate through the post by the physician who follows them up in the Haemophilia Treatment Centre. If they agree to participate, they will be asked to fill a self-administered questionnaire in. This questionnaire will include items focusing on the following outcomes:
* occupational outcomes:
* access to higher education and high-school graduation,
* age at the start of working life,
* degree of employment (unemployment / part-time employment / full-time employment),
* sheltered employment,
* job security (temporary / permanent contract / self-employment),
* type of job (using the International Standard Classification of Occupations)
* socio-demographic outcomes:
* age
* living with a partner
* having dependent children
* psycho-behavioural outcomes:
* depressive symptomatology (using the Center for Epidemiologic Studies Depression (CES-D) scale)
* quality of life (using the generic scale 36-Item Short Form Survey (SF-12) and the haemophilia-specific scale Haem-A-QoL)
* anxiety (using the Strate-Trait Anxiety Inventory (STAI) scale)
* coping strategies (using the BriefCOPE)
* perceived impact of haemophilia on employment
* participating in therapeutic education sessions
* member of the Association française des hémophiles (AFH)
Clinical outcomes will be recorded via the FranceCoag cohort database (type of haemophilia, treatment, presence of an inhibitor, comorbidities as HIV and HCV infections).
Occupational outcomes of the participants will be described, and compared to the French national population. Expected distributions of the outcomes will be established by using data from the French National Institute for Statistics and Economic Studies. Observed and expected distributions will be compared. The modulating role of individual characteristics (including the period of birth, the presence of an inhibitor, comorbidities as HIV and HCV infections) in occupational issues will be assessed.
Expected results:
The results of this project will establish an updated picture of the occupational situation of French adults with severe haemophilia. By comparing the evolution of the occupational situation among them with the evolution in adults from the general population, the investigators will be able to assess the possibly different impact of the changes of the socio-economic context on the occupational situation of adults with severe haemophilia. The results will also establish a new picture of the occupational situation for the new generation of adults who was not concerned by the survey carried out about ten years ago. This sub-group is of particular interest as the impact of the disease on their life might have been different (major therapeutic progresses, no exposition to transfusion-transmitted infections).
Via the French haemophilia society (AFH) which is a partner of the present project, the results from the objectives 1 to 4 will be used for the education, training and awareness of patient resources, for the development of therapeutic patient education sessions focused on occupational issues, and for the drawing up of a brochure intended for patients.
Survivors of childhood leukemia from the French LEA cohort who present a higher rate of employment than the general population, but a lower access to a steady job could be an interesting comparative group for the fifth objective. As numerous actions are proposed to facilitate the occupational integration of survivors of cancer, the identification of the haemophilia-specific difficulties could help the decisions-makers to allocate means according to the specific needs of the persons with haemophilia.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients aged from 18 to 65 years old
* Patients enrolled in the FranceCoag national cohort
* Patients affiliated to the French social security system
* Non opposition to participate in the study
Exclusion Criteria
* Patients under the age of 18 or over the age of 65
* Patients with comprehension problems
* Patients unable to read or to write
* Vulnerable patients
* Opposition to participate in the study
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique Hopitaux De Marseille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Urielle DESALBRES
Role: STUDY_DIRECTOR
Assistance Publique Hôpitaux de Marseille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital de la Timone Assistance Publique Hôpitaux de Marseille
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-51
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.